1Lock HR,Sacks SH,Robson MG.Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix production.Am J Physiol Renal Physiol,2007,292:F76-81.
2Tumlin JA,Miller D,Near M,et al.A prospective,open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.Clin J Am Soc Nephrol,2006,1:109-116.
3Fervenza FC,Fitzpatrick PM,Mertz J,et al.Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies.Nephrol Dial Transplant,2004,19:1288-1292.
4Cho ME,Hurley JK,Kopp JB.Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity.Am J Kidney Dis,2007,49:310-317.
5Morrisett JD,Abdel-Fattah G,Kahan BD.Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.Transplant Proc,2003,35(3 Suppl):143S-150S.
